BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Tripartite motif-containing 24 (Trim24; TIF1)

June 2, 2016 7:00 AM UTC

Patient sample and cell culture studies suggest inhibiting Trim24 could help treat castration-resistant prostate cancer (CRPC). In patient samples, high tumor levels of Trim24 were associated with the...